Does Blue Cross Blue Shield of Massachusetts Cover Trulicity?

How BCBS MA Classifies Trulicity on Its Formulary

Blue Cross Blue Shield of Massachusetts places Trulicity (dulaglutide) on its drug formulary under brand-name tiers for most commercial, HMO Blue, and PPO plan types. The exact tier varies by plan year and product line, but dulaglutide generally lands on Tier 3 (preferred brand) or Tier 4 (non-preferred brand).

Tier placement matters because it directly determines your copay or coinsurance. A Tier 3 placement on a typical BCBS MA HMO Blue plan might carry a $50 to $75 copay per 30-day supply, while a Tier 4 placement could push that figure above $100. High-deductible health plans (HDHPs) paired with health savings accounts (HSAs) often require you to pay the full negotiated price until you meet your annual deductible, which can mean $800 or more out of pocket for a single fill at retail price.

BCBS MA publishes its formulary lists annually, and mid-year changes do occur. The most reliable way to verify Trulicity's current tier on your specific plan is to log in to the BCBS MA member portal or call the number on the back of your insurance card. Pharmacists can also run a real-time benefits check at the point of sale. The American Diabetes Association's Standards of Care recommend GLP-1 receptor agonists like dulaglutide as second-line therapy after metformin for patients with type 2 diabetes, particularly those with established atherosclerotic cardiovascular disease [1]. That guideline standing helps support formulary inclusion across major insurers.

Prior Authorization Requirements for Trulicity

Nearly all BCBS MA plans require prior authorization (PA) before they will cover Trulicity. This is standard practice across GLP-1 receptor agonist prescriptions, not unique to dulaglutide.

Your prescribing clinician typically needs to document that you have a confirmed diagnosis of type 2 diabetes, that you have tried and failed (or have a contraindication to) metformin, and that your current HbA1c remains above target despite existing therapy. The 2024 ADA Standards of Care define an HbA1c target of <7% for most adults, though individualized goals may range from <6.5% to <8% depending on age, comorbidities, and hypoglycemia risk [1].

The PA submission process usually takes 24 to 72 hours. BCBS MA accepts electronic prior authorization (ePA) through platforms like CoverMyMeds and Surescripts, which can cut turnaround to under 24 hours. If your PA is denied, you have the right to appeal. National data from the AMA's 2023 Prior Authorization Physician Survey found that 35% of physicians reported a PA-related adverse event, and 94% said PA caused care delays [2]. Dr. Jack Resneck Jr., former AMA president, stated: "Prior authorization too often causes harmful delays in necessary care and creates significant administrative burdens that take physicians away from patient care" [2].

If you receive a denial, ask your physician's office to file a peer-to-peer review first. This is a phone call between your doctor and the insurer's medical reviewer. Many denials reverse at this stage.

What Trulicity Costs with BCBS MA Insurance

Out-of-pocket costs for Trulicity with BCBS MA coverage depend on your plan's tier structure, whether you have met your deductible, and whether you apply manufacturer or pharmacy discount programs.

For a commercial BCBS MA PPO plan with Trulicity on Tier 3, a typical monthly copay falls between $50 and $75. On plans where dulaglutide sits on Tier 4 or a specialty tier, coinsurance of 20% to 33% is common, which can translate to $150 to $300 per month at the average wholesale price. Eli Lilly's Trulicity Savings Card can bring commercially insured patients' costs down to $25 per month for up to 24 months, but this card cannot be used with Medicare, Medicaid, or other government-funded insurance [3].

For BCBS MA Medicare Advantage members, Trulicity coverage follows the plan's Part D formulary. Under Medicare Part D, once you enter the coverage gap (the "donut hole"), you pay 25% of the plan's negotiated price for brand-name drugs. The Inflation Reduction Act of 2022 capped annual out-of-pocket Part D spending at $2,000 starting in 2025, which provides meaningful relief for patients on expensive injectable diabetes medications [4]. Before that cap, some Medicare beneficiaries reported spending $3,000 to $5,000 annually on GLP-1 receptor agonists alone.

Massachusetts state law (M.G.L. c. 175, § 47W) mandates that fully insured health plans cover prescription drugs for the treatment of diabetes, including injectable medications. This mandate applies to most BCBS MA plans issued in the state. Self-funded employer plans (ERISA plans) are exempt from state mandates, so employees on self-funded BCBS MA administered plans should verify coverage separately.

Step Therapy: Will BCBS MA Make You Try Other Drugs First?

Step therapy protocols require patients to try and fail cheaper medications before the insurer approves a more expensive option. BCBS MA commonly applies step therapy to GLP-1 receptor agonists, including Trulicity.

The most frequent step therapy requirement is a documented trial of metformin lasting at least 90 days. Some plans also require a trial of a sulfonylurea or an SGLT2 inhibitor before approving dulaglutide. The clinical rationale aligns with ADA guidelines, which recommend metformin as first-line pharmacotherapy for most adults with type 2 diabetes [1]. If your physician believes step therapy is clinically inappropriate for your case (for example, if you have chronic kidney disease with an eGFR <30 mL/min/1.73 m², where metformin is contraindicated), they can request a step therapy exception.

Massachusetts passed step therapy reform legislation (Chapter 108 of the Acts of 2018) that requires insurers to grant exceptions when a patient meets specific clinical criteria, including when the required first-step drug is expected to be ineffective based on the patient's medical history. The law also mandates that insurers respond to exception requests within 24 hours for urgent cases and 72 hours for standard cases.

A 2019 analysis published in Health Affairs found that step therapy protocols for diabetes medications delayed appropriate treatment by an average of 2.2 months [5]. During that delay, patients' HbA1c levels may drift higher, increasing the risk of microvascular complications.

How Trulicity Compares to Other Covered GLP-1 Options on BCBS MA

BCBS MA formularies typically list multiple GLP-1 receptor agonists, and the tier placement of each drug shifts from year to year based on rebate negotiations. Understanding the alternatives can help you and your physician choose the most cost-effective option.

Ozempic (semaglutide) often shares the same formulary tier as Trulicity on BCBS MA plans, though some plan years have placed one as preferred over the other. In the SUSTAIN-7 trial (N=1,201), semaglutide 0.5 mg and 1.0 mg demonstrated greater HbA1c reduction compared to dulaglutide 0.75 mg and 1.5 mg at 40 weeks (1.5% vs. 1.1% for the higher doses) [6]. Semaglutide also produced more weight loss (6.5 kg vs. 3.0 kg at the higher doses). These efficacy differences may factor into your physician's recommendation.

Mounjaro (tirzepatide), a dual GIP/GLP-1 receptor agonist, showed even greater glycemic and weight outcomes in the SURPASS program. In SURPASS-2 (N=1,879), tirzepatide 15 mg reduced HbA1c by 2.58% compared to semaglutide 1.0 mg's 1.86% reduction at 40 weeks [7]. Mounjaro may sit on a higher tier or require separate prior authorization on BCBS MA plans due to its cost.

Victoza (liraglutide), an older daily-injection GLP-1 agonist, may appear on a lower (cheaper) tier. The LEADER trial (N=9,340) demonstrated that liraglutide reduced major adverse cardiovascular events by 13% compared to placebo over a median 3.8 years in patients with type 2 diabetes and high cardiovascular risk [8]. Trulicity showed a similar cardiovascular benefit in the REWIND trial (N=9,901), where dulaglutide 1.5 mg reduced the composite MACE endpoint by 12% over a median 5.4 years [9].

Dr. Robert Gabbay, Chief Scientific and Medical Officer at the ADA, has noted: "Choosing among GLP-1 receptor agonists should consider not just efficacy but also patient preference for dosing frequency, device design, and insurance coverage, since adherence depends on affordability and convenience" [10].

How to Get Trulicity Approved by BCBS MA

Getting your Trulicity prescription covered requires coordination between you, your prescriber, and the insurer. A structured approach reduces delays.

Start by confirming formulary status. Call BCBS MA member services or check the online formulary tool to verify Trulicity's tier and any PA or step therapy requirements for your exact plan. Have your member ID ready.

Next, ensure your medical records include documentation of your type 2 diabetes diagnosis (ICD-10 code E11.x), your current and past HbA1c values, and a list of diabetes medications you have previously tried. If step therapy applies, records should show the dates and duration of each prior medication trial, along with the reason for discontinuation (inadequate efficacy, adverse effects, or contraindication).

Your physician's office submits the PA request. Electronic submission through CoverMyMeds is fastest. Include supporting clinical notes and relevant lab results with the initial submission rather than waiting for the insurer to request them. This proactive documentation can prevent a "pend" status that adds days to the process.

If denied, file an internal appeal within 30 days. Reference your clinical history, cite applicable ADA guidelines [1], and include any relevant Massachusetts insurance mandates. If the internal appeal fails, you have the right to an external review through the Massachusetts Office of Patient Protection, which assigns an independent reviewer. The external review decision is binding on the insurer.

Trulicity Coverage for Specific BCBS MA Plan Types

Coverage details differ across BCBS MA's product lines. Here is what to expect for the most common plan types.

HMO Blue and HMO Blue New England: These plans use a closed formulary with tighter tier controls. Trulicity is generally included but may require referral to an endocrinologist before PA approval. Copays tend to be lower than PPO plans (often $40 to $60 for Tier 3).

Blue Care Elect (PPO): The PPO formulary is broader, and Trulicity typically appears on Tier 3. Out-of-network pharmacies may charge a higher copay or coinsurance rate. Use in-network retail or mail-order pharmacy options to minimize cost.

Medicare Blue (Medicare Advantage): Trulicity coverage follows the Part D formulary. The $2,000 annual out-of-pocket cap under the Inflation Reduction Act applies [4]. Medicare Advantage plans may impose quantity limits (typically four pens per 28-day supply for the once-weekly dosing).

Medex (Medicare Supplement): Medex plans do not include prescription drug coverage. You need a separate Part D plan to cover Trulicity.

Blue Cross Student Health Plans: Coverage varies by institution. Some university-sponsored BCBS MA plans classify Trulicity as specialty tier with coinsurance rather than a flat copay. Contact your school's student health office for formulary details.

For self-funded employer plans administered by BCBS MA, the employer sets the formulary and PA rules, not BCBS MA. Your employer's benefits department or HR office is the correct contact for coverage questions on these plans.

Using Pharmacy Benefits to Lower Your Trulicity Cost

Even with BCBS MA coverage, Trulicity can be expensive at the pharmacy counter. Several strategies can reduce what you pay.

Mail-order pharmacy programs through BCBS MA often provide a 90-day supply for the cost of two monthly copays. This 33% savings adds up over a year of continuous therapy. BCBS MA's preferred mail-order partner (typically Express Scripts or a similar PBM) processes these orders.

Eli Lilly's Trulicity Savings Card is the single most impactful cost-reduction tool for commercially insured patients. Eligible patients pay as little as $25 per month, with Lilly covering up to $150 per prescription [3]. The card is not valid for government-funded insurance recipients.

For patients whose insurance requires coinsurance rather than a flat copay, manufacturer copay assistance programs can still cap your out-of-pocket amount. Ask your pharmacist to run the savings card alongside your insurance claim at the point of sale.

Patient assistance programs (PAPs) from Lilly (called "Lilly Cares") provide free Trulicity to patients who are uninsured or underinsured and meet income eligibility criteria (generally household income at or below 400% of the federal poverty level). Application requires proof of income and a prescription from your provider [3].

The GoodRx and RxSaver discount platforms occasionally offer competitive cash prices, but for most BCBS MA members, using insurance plus the manufacturer savings card yields the lowest net cost. Compare both options at the pharmacy before filling.